Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:26 PM
Ignite Modification Date:
2025-12-24 @ 4:26 PM
NCT ID:
NCT01733966
Eligibility Criteria:
Inclusion Criteria:
* Adult
* Recovering of written and dated informed consent form
* Social Security medical cover
* Left Iliac Fossa (LIF) pain
* Moderate fever (\>37.8°C)
* Sensitivity/defence during LIF palpation
Biological results :
* CRP \> 10mg/L
* NFS \> 10G/L
* Neutrophil Granulocytosis \> 75%
* Radiological results - presence to the scan :diverticul \& pericolic infiltration
Exclusion Criteria:
* Patients treated by antibiotherapy in the last 15 days prior inclusion
* Patients treated by morphinic drug
* Patients treated by anticoagulant drug
* Pregnant or breast-feeding women
* Patients presenting allergy to active principal, to galactose
* Patients having taking part in another study in the last 3 months prior inclusion
* Patients unable to comply with the study requirements
* Patients presenting Chronic affection inconsistent with the study
* Patients presenting high fever
* Patients presenting abdominal contracture
* Patients presenting immunosuppression
* Radiological sign of complication (abscess\>3cm)
* Patients presenting Pathology inconsistent with efficacy evaluatio
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT01733966
Study Brief:
Protocol Section:
NCT01733966